Mitochondrial neurogastrointestinal encephalomyopathy

Area of Science:

• Genetics
• Neurology
• Mitochondrial Biology

Background:

• Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder.
• It arises from nuclear gene mutations affecting mitochondrial function.
• Thymidine phosphorylase (TP) gene mutations are a known cause of MNGIE.

Observation:

• A 29-year-old Iranian male presented with gastrointestinal issues, hearing loss, ophthalmoplegia, and sensorimotor neuropathy.
• Elevated muscle enzymes and leukoencephalopathic changes on MRI were noted.
• The patient exhibited significant thymidineuria.

Findings:

• The patient's clinical presentation and biochemical findings were consistent with MNGIE.
• A nuclear mutation in the thymidine phosphorylase gene was identified as the underlying cause.
• Elevated urinary thymidine levels served as a key diagnostic biomarker.

Implications:

• This case highlights the importance of recognizing MNGIE in patients with unexplained gastrointestinal and neurological symptoms.
• Accurate diagnosis relies on a combination of clinical evaluation, neuroimaging, and metabolite analysis.
• Understanding the genetic basis of MNGIE aids in genetic counseling and potential therapeutic strategies.